WordNet

tissue consisting of glial cells with sheetlike processes that form the myelin sheath of nerve fibers (同)oligodendria
an abnormal new mass of tissue that serves no purpose (同)tumour, neoplasm

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 未分化乏突起膠腫のマネージメント management of anaplastic oligodendroglial tumors
2. 乏突起膠腫の臨床的特徴、病理、および予後因子 clinical features pathology and prognostic factors for oligodendroglial tumors
3. 神経膠腫の分類 classification of gliomas
4. 低悪性度神経膠腫の診断および分類 diagnosis and classification of low grade gliomas
5. 悪性神経膠腫の病因と分子生物学 pathology and molecular pathogenesis of diffuse gliomas

1p/19q-driven prognostic molecular classification for high-grade oligodendroglial tumors.

Jiang H1, Zhang Z, Ren X, Zeng W, Jia W, Wang J, Lin S.
Journal of neuro-oncology.J Neurooncol.2014 Dec;120(3):607-14. doi: 10.1007/s11060-014-1593-0. Epub 2014 Aug 24.
The subjectivity in pathological diagnosis of anaplastic oligoastrocytoma (AOA) and uncertainty in designation of glioblastoma with oligodendroglioma component (GBMO) were two major dilemmas which puzzled neuro-pathologists and neurosurgeons. The present study was designed to project a molecular cla
PMID 25151507

Prognostic relevance of histomolecular classification of diffuse adult high grade gliomas with necrosis.

Figarella-Branger D1, Mokhtari K, Colin C, Uro-Coste E, Jouvet A, Dehais C, Carpentier C, Villa C, Maurage CA, Eimer S, Polivka M, Vignaud JM, Laquerriere A, Sevestre H, Lechapt-Zalcman E, Quintin-Roué I, Aubriot-Lorton MH, Diebold MD, Viennet G, Adam C, Loussouarn D, Michalak S, Rigau V, Heitzmann A, Vandenbos F, Forest F, Chiforeanu D, Tortel MC, Labrousse F, Chenard MP, Nguyen AT, Varlet P, Kemeny JL, Levillain PM, Cazals-Hatem D, Richard P, Delattre JY; POLA Network.
Brain pathology (Zurich, Switzerland).Brain Pathol.2014 Nov 18. doi: 10.1111/bpa.12227. [Epub ahead of print]
BACKGROUND: Diffuse adult high grade gliomas (HGG) with necrosis encompass anaplastic oligodendrogliomas (AO) with necrosis (grade III), glioblastomas (GBM, grade IV) and glioblastomas with an oligodendroglial component (GBMO, grade IV). Here, we aimed to search for prognostic relevance of histologi
PMID 25407774

Pattern of care of anaplastic oligodendroglioma and oligoastrocytoma in a Korean population: the Korean radiation oncology group study 13-12.

Yu T1, Kang HC, Lim DH, Kim IH, Chung WK, Suh CO, Choi BO, Cho KH, Cho JH, Kim JH, Park CK, Hong YK, Kim IA.
Journal of neuro-oncology.J Neurooncol.2014 Nov 13. [Epub ahead of print]
This study investigated the treatment of anaplastic oligodendroglial tumors across nine Korean institutions. We reviewed the medical records from 381 patients with histologically confirmed anaplastic oligodendroglioma or anaplastic oligoastrocytoma (AOA) from 2000 to 2010. Clinical factors and treat
PMID 25391968

佐々木光
脳神経外科ジャーナル 23(7), 547-558, 2014
BCNU徐放剤とベバシズマブ (BEV) について, これまでの知見と薬剤の特徴について概説し, また退形成性乏突起膠腫と高齢者膠芽腫における最新のエビデンスを紹介する. BCNU徐放剤の留置により, 再発ならびに初発悪性神経膠腫患者の生存期間が延長した. 再発膠芽腫の80%以上がBEVにより造影領域の縮小を示した. 初発膠芽腫に対して放射線/テモゾロミド (TMZ) 併用療法にBEVを併用す …
NAID 130004842124

沖田典子,丸野元彦,吉澤秀憲,鈴木強
Neuro-Oncologyの進歩 20(1), 50-53, 2014
… 1p/19q deletions are prognostic factors in oligodendroglial tumors and predict better survival after both chemotherapy and radiotherapy. …
NAID 130004648356

Fluorescence In Situ Hybridization(FISH) Cut-off Value : Loss of Heterozygosity(LOH) on 1p and 19q in Oligodendroglial and Oligoastrocytic Tumors and Glioblastomas with an Oligodendroglial Component